Aptevo Therapeutics Inc (NASDAQ: APVO) on Monday, plunged -12.09% from the previous trading day, before settling in for the closing price of $0.50. Within the past 52 weeks, APVO’s price has moved between $0.45 and $44.03.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 2.12% over the past five years. The company achieved an average annual earnings per share of 81.87%. With a float of $5.35 million, this company’s outstanding shares have now reached $5.55 million.
Let’s look at the performance matrix of the company that is accounted for 42 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Aptevo Therapeutics Inc (APVO) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Aptevo Therapeutics Inc is 3.61%, while institutional ownership is 12.08%.
Aptevo Therapeutics Inc (APVO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -4.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.40% during the next five years compared to 80.96% growth over the previous five years of trading.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
Aptevo Therapeutics Inc (APVO) is currently performing well based on its current performance indicators. A quick ratio of 1.72 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -452.26, a number that is poised to hit -4.21 in the next quarter and is forecasted to reach -14.49 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
Aptevo Therapeutics Inc (NASDAQ: APVO) saw its 5-day average volume 1.29 million, a negative change from its year-to-date volume of 2.2 million. As of the previous 9 days, the stock’s Stochastic %D was 6.75%. Additionally, its Average True Range was 0.22.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 0.12%, which indicates a significant decrease from 1.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 135.10% in the past 14 days, which was lower than the 182.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7417, while its 200-day Moving Average is $7.0703. Nevertheless, the first resistance level for the watch stands at $0.4645 in the near term. At $0.4891, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5099. If the price goes on to break the first support level at $0.4191, it is likely to go to the next support level at $0.3983. The third support level lies at $0.3737 if the price breaches the second support level.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
Market capitalization of the company is 2.44 million based on 5,547K outstanding shares. Right now, sales total 0 K and income totals -24,130 K. The company made 0 K in profit during its latest quarter, and -6,310 K in sales during its previous quarter.
